-+ 0.00%
-+ 0.00%
-+ 0.00%

ALCON ACQUIRES NEUROTECH AND ENCELTO, THE ONLY FDA-APPROVED TREATMENT FOR MACTEL TYPE 2

Reuters·10/20/2026 20:35:00

Please log in to view news